North America was Bio Key International’s largest region in fiscal 2025, bringing in $1.73M of $3.91M (44%).
| Geography | FY 2020 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|
| North America | $1.97M | $2.41M | $1.73M | |
| Emesa | $1.80M | $1.28M | $1.17M | |
| Africa | $552.63K | $1.49M | $781.77K | |
| Emea | — | — | — | |
| Asia | $67.84K | $91.31K | $232.26K | |
| South America | — | — | — | |
| Total | $4.39M | $5.27M | $3.91M |
Bio Key International brought in $3.91M from its four regions in fiscal 2025, the year ended December 31, 2025. That was down 25.9% from $5.27M in fiscal 2024. North America was the largest at $1.73M (44.1%), ahead of Emesa at $1.17M (29.9%) and Africa at $781.77K (20.0%). The remaining region, Asia, brought in $232.26K.
Compared with fiscal 2024, Asia grew fastest, up 154.4% to $232.26K, while Africa fell the most, down 47.5% to $781.77K. From fiscal 2023 to 2025, combined revenue from these regions fell from $4.39M to $3.91M, a compound annual decline of 5.6%. North America's share of the total fell from 44.9% to 44.1%.
License was Bio Key International’s largest product and service line in fiscal 2025, bringing in $1.73M of $3.55M (49%).
| Product and Service | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2023 | FY 2023 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| License | $2.12M | $3.43M | $6.53M | $8.43M | $1.97M | $2.41M | $1.73M | |||
| Service | $1.27M | — | — | — | $1.12M | $898.69K | $829.76K | |||
| Hardware | $422.28K | — | — | — | $1.01M | $391.76K | $997.27K | |||
| Total | $3.82M | $3.43M | $6.53M | $8.43M | $4.10M | $3.70M | $3.55M |
Bio Key International brought in $3.55M from its three product and service lines in fiscal 2025, the year ended December 31, 2025. That is less than the $3.91M it reports by geography, so these lines do not cover all of its revenue. License was the largest at $1.73M (48.6%), ahead of Hardware at $997.27K (28.1%) and Service at $829.76K (23.4%).
Compared with fiscal 2024, Hardware grew fastest, up 154.6% to $997.27K, while License fell the most, down 28.4% to $1.73M.
Previously Reported was Bio Key International’s largest revenue line in fiscal 2023, bringing in $4.66M of $5.90M (79%).
| Revision of Prior Period | FY 2023 | FY 2023 | FY 2023 |
|---|---|---|---|
| Previously Reported | $3.08M | $5.01M | $4.66M |
| Revision Of Prior Period, Adjustment | -$900.00K | -$900.00K | $1.24M |
| Total | $2.18M | $4.11M | $5.90M |
Bio Key International brought in $5.90M from its two revenue lines in fiscal 2023, the year ended September 30, 2023. That was up 43.5% from $4.11M in fiscal 2023. Previously Reported was the largest at $4.66M (79.1%), ahead of Revision Of Prior Period, Adjustment at $1.24M (20.9%).
Bio Key International (BKYI) reports its revenue by geography, by product and service and by revision of prior period. In fiscal 2025, North America was its largest region, bringing in $1.73M (44.1% of the total), followed by Emesa at $1.17M (29.9%).
North America was Bio Key International's largest region in fiscal 2025, bringing in $1.73M, or 44.1% of the $3.91M total across its four regions.
License was Bio Key International's largest product and service line in fiscal 2025, bringing in $1.73M, or 48.6% of the $3.55M total across its three product and service lines.
Previously Reported was Bio Key International's largest revenue line in fiscal 2023, bringing in $4.66M, or 79.1% of the $5.90M total across its two revenue lines.
Among Bio Key International's regions that make up at least 2% of revenue, Asia grew fastest in fiscal 2025, up 154.4% from $91.31K to $232.26K.
Every figure comes from Bio Key International's annual financial filings, as reported. Each line keeps the name Bio Key International gives it, and years follow its fiscal calendar.
Bio Key International's revenue by geography goes back to fiscal 2020, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.